| Mario Dante Lacerna, MD | |
|
1501 W Chisholm St, Alpena, MI 49707-1401 | |
| (888) 356-7151 | |
| (989) 356-8117 |
| Full Name | Mario Dante Lacerna |
|---|---|
| Gender | Male |
| Speciality | Radiation Oncology |
| Experience | 32 Years |
| Location | 1501 W Chisholm St, Alpena, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326130725 | NPI | - | NPPES |
| 4303114 | Medicaid | MI | |
| 4375200 | Medicaid | FL | |
| FT108Y | Other | FL | MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0001X | Radiology - Radiation Oncology | 4301059592 (Michigan) | Primary |
| 2085R0001X | Radiology - Radiation Oncology | ME111595 (Florida) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Midmichigan Medical Center - Alpena | Alpena, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northeastern Michigan Cancer Center | 0840285904 | 4 |
News Archive
"The sweeping health-care package unveiled this week by the White House appears to face big hurdles in the House, with abortion and unease among moderates potential stumbling blocks to winning passage of the legislation," The Wall Street Journal reports. President Obama's proposal Monday has "drawn mixed reviews from moderate Democrats," who face electoral pressures and in some cases dispute specific policy ideas. Sen. Ben Nelson, D-Neb., for instance, "criticized a new White House provision that would give the federal government powers to hold down insurance premiums, saying that should be up to the states" (Adamy and Hitt, 2/24).
aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address rare diseases, announced today the European Commission (EC) has granted orphan drug designation to Resolaris for the treatment of facioscapulohumeral muscular dystrophy (FSHD).
Heart attacks and strokes — the leading causes of death in the United States and other developed countries — may have been rare for the vast majority of human history, suggests a study to be published in PLoS ONE on Tuesday, August 11.
Canada's leading health care associations are calling on federal and provincial/territorial health ministers to tackle a number of pressing issues at the ministers' annual meeting, taking place in Winnipeg September 17.
In far too many cases over the years, scientists have discovered promising new cancer treatments, only to report later that the tumor cells found ways to become resistant. These disappointing results have made overcoming drug resistance a major goal in cancer research.
› Verified 6 days ago
| Entity Name | Mymichigan Medical Center Alpena |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508332792 PECOS PAC ID: 8527969922 Enrollment ID: O20040415000495 |
News Archive
"The sweeping health-care package unveiled this week by the White House appears to face big hurdles in the House, with abortion and unease among moderates potential stumbling blocks to winning passage of the legislation," The Wall Street Journal reports. President Obama's proposal Monday has "drawn mixed reviews from moderate Democrats," who face electoral pressures and in some cases dispute specific policy ideas. Sen. Ben Nelson, D-Neb., for instance, "criticized a new White House provision that would give the federal government powers to hold down insurance premiums, saying that should be up to the states" (Adamy and Hitt, 2/24).
aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address rare diseases, announced today the European Commission (EC) has granted orphan drug designation to Resolaris for the treatment of facioscapulohumeral muscular dystrophy (FSHD).
Heart attacks and strokes — the leading causes of death in the United States and other developed countries — may have been rare for the vast majority of human history, suggests a study to be published in PLoS ONE on Tuesday, August 11.
Canada's leading health care associations are calling on federal and provincial/territorial health ministers to tackle a number of pressing issues at the ministers' annual meeting, taking place in Winnipeg September 17.
In far too many cases over the years, scientists have discovered promising new cancer treatments, only to report later that the tumor cells found ways to become resistant. These disappointing results have made overcoming drug resistance a major goal in cancer research.
› Verified 6 days ago
| Entity Name | Radiation Oncology Alliance |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477587061 PECOS PAC ID: 5890780951 Enrollment ID: O20040417000471 |
News Archive
"The sweeping health-care package unveiled this week by the White House appears to face big hurdles in the House, with abortion and unease among moderates potential stumbling blocks to winning passage of the legislation," The Wall Street Journal reports. President Obama's proposal Monday has "drawn mixed reviews from moderate Democrats," who face electoral pressures and in some cases dispute specific policy ideas. Sen. Ben Nelson, D-Neb., for instance, "criticized a new White House provision that would give the federal government powers to hold down insurance premiums, saying that should be up to the states" (Adamy and Hitt, 2/24).
aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address rare diseases, announced today the European Commission (EC) has granted orphan drug designation to Resolaris for the treatment of facioscapulohumeral muscular dystrophy (FSHD).
Heart attacks and strokes — the leading causes of death in the United States and other developed countries — may have been rare for the vast majority of human history, suggests a study to be published in PLoS ONE on Tuesday, August 11.
Canada's leading health care associations are calling on federal and provincial/territorial health ministers to tackle a number of pressing issues at the ministers' annual meeting, taking place in Winnipeg September 17.
In far too many cases over the years, scientists have discovered promising new cancer treatments, only to report later that the tumor cells found ways to become resistant. These disappointing results have made overcoming drug resistance a major goal in cancer research.
› Verified 6 days ago
| Entity Name | Northeastern Michigan Cancer Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275567869 PECOS PAC ID: 0840285904 Enrollment ID: O20040417000515 |
News Archive
"The sweeping health-care package unveiled this week by the White House appears to face big hurdles in the House, with abortion and unease among moderates potential stumbling blocks to winning passage of the legislation," The Wall Street Journal reports. President Obama's proposal Monday has "drawn mixed reviews from moderate Democrats," who face electoral pressures and in some cases dispute specific policy ideas. Sen. Ben Nelson, D-Neb., for instance, "criticized a new White House provision that would give the federal government powers to hold down insurance premiums, saying that should be up to the states" (Adamy and Hitt, 2/24).
aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address rare diseases, announced today the European Commission (EC) has granted orphan drug designation to Resolaris for the treatment of facioscapulohumeral muscular dystrophy (FSHD).
Heart attacks and strokes — the leading causes of death in the United States and other developed countries — may have been rare for the vast majority of human history, suggests a study to be published in PLoS ONE on Tuesday, August 11.
Canada's leading health care associations are calling on federal and provincial/territorial health ministers to tackle a number of pressing issues at the ministers' annual meeting, taking place in Winnipeg September 17.
In far too many cases over the years, scientists have discovered promising new cancer treatments, only to report later that the tumor cells found ways to become resistant. These disappointing results have made overcoming drug resistance a major goal in cancer research.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mario Dante Lacerna, MD 3621 South State Street, 700 Kms Place, Ann Arbor, MI 48108 Ph: (734) 936-2047 | Mario Dante Lacerna, MD 1501 W Chisholm St, Alpena, MI 49707-1401 Ph: (888) 356-7151 |
News Archive
"The sweeping health-care package unveiled this week by the White House appears to face big hurdles in the House, with abortion and unease among moderates potential stumbling blocks to winning passage of the legislation," The Wall Street Journal reports. President Obama's proposal Monday has "drawn mixed reviews from moderate Democrats," who face electoral pressures and in some cases dispute specific policy ideas. Sen. Ben Nelson, D-Neb., for instance, "criticized a new White House provision that would give the federal government powers to hold down insurance premiums, saying that should be up to the states" (Adamy and Hitt, 2/24).
aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address rare diseases, announced today the European Commission (EC) has granted orphan drug designation to Resolaris for the treatment of facioscapulohumeral muscular dystrophy (FSHD).
Heart attacks and strokes — the leading causes of death in the United States and other developed countries — may have been rare for the vast majority of human history, suggests a study to be published in PLoS ONE on Tuesday, August 11.
Canada's leading health care associations are calling on federal and provincial/territorial health ministers to tackle a number of pressing issues at the ministers' annual meeting, taking place in Winnipeg September 17.
In far too many cases over the years, scientists have discovered promising new cancer treatments, only to report later that the tumor cells found ways to become resistant. These disappointing results have made overcoming drug resistance a major goal in cancer research.
› Verified 6 days ago
James Weeks, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1501 W Chisholm St, Alpena, MI 49707 Phone: 989-356-7390 | |
Dr. Ben Edward Eggleston, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 704 W Washington Ave, Alpena, MI 49707 Phone: 952-595-1100 Fax: 612-294-4903 | |
Dr. Charles S Spann, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1501 W Chisholm St, Alpena, MI 49707 Phone: 989-356-7390 | |
Kyle Clifford Cuneo, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1501 West Chisholm St, Alpena, MI 49707 Phone: 888-356-7151 | |
Julie M Forstner, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1501 W Chisholm St, Alpena, MI 49707 Phone: 989-356-7353 |